BKD
Brookdale Senior Living Inc. Health Care Services-Nursing & Personal Care Facilities Russell 3000
$10.39Close
$2.5BMarket cap
$9.11 – $16.7752-week range
Nov 6, 2026Next report · before the open
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 15 · weaker than 85% of stocks over 12 months
- Far from its high 38% below its 52-week high
- Results soon Nov 6, 2026, in 5 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
38%
1wk
up 3.1%
price change
1mo
down 4.1%
price change
12-month return
up 12%
market up 11% ·
its own up 5%
F-score
5 / 9
Mixed
Altman Z″
-2.36
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
up 0.2%
EBIT / enterprise value
Cheaper than
26%
of the market · expensive
Revenue growth
up 2%
year on year
EPS growth
—
latest quarter
Sales growth
down 12%
latest quarter · -6 pts
ROE
—
return on equity
Free cash margin
up 1%
$16.5M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
10.3×
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- profitability slipped from last year
- issued more shares
- assets working less efficiently
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
- gross margin widened
Repair signals
- FCF turned positive ($-35M → $17M)
Trade setup
ATR%
3.4%
$0.35 a day · 2×ATR $9.68
RS
15 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
1.1×
vs 50-day average
Up/down volume
0.73
50 sessions
Implied move
—
no option chain · report Nov 6, 2026
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Liabilities exceed assets Shareholders' equity is negative at -$44.8M as of Dec 31, 2025. What is left for shareholders after creditors is, on the balance sheet, less than nothing.
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Heavily indebted Net debt is 10.3 times EBITDA — roughly 10 years of earnings before interest, tax and depreciation to repay borrowings in full.
- Shareholders diluted The share count rose 18.9% over the year, from 200m to 238m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Oct 8, 2026
Results reaction
Oct 8, 2026-6% vs market2 sessions after results
Financials
- Gross 26%
- Net -8%
- Free cash 1%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $3.5B | $2.8B | $2.8B | $3.0B | $3.1B | $3.2B |
| Gross margin | 23% | 18% | 21% | 25% | 26% | 26% |
| Operating income | -$97.7M | -$216.9M | -$42.7M | $18.4M | $46.5M | $13.5M |
| Net income | $82.0M | -$99.3M | -$238.4M | -$189.0M | -$201.9M | -$262.7M |
| Net margin | 2% | -4% | -8% | -6% | -6% | -8% |
| Earnings per share | $0.44 | -$0.54 | -$1.25 | -$0.84 | -$0.89 | -$1.12 |
| Free cash flow | $19.8M | -$271.3M | -$193.6M | -$70.3M | -$35.1M | $16.5M |
| Free cash margin | 1% | -10% | -7% | -2% | -1% | 1% |
| Cash | $380.4M | $347.0M | $398.9M | $278.0M | $308.9M | $279.1M |
| Long-term debt | $3.8B | $3.8B | $3.8B | $3.7B | $4.0B | $4.2B |
| Shareholders' equity | $800.4M | $697.4M | $582.6M | $403.7M | $212.5M | -$44.8M |
| Shares outstanding | 187.80m | 186.96m | 187.25m | 188.25m | 200.02m | 237.75m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 10, 2026 | Quarterly ↗ | Jun 30, 2026 | 41d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Feb 19, 2026 | Annual ↗ | Dec 31, 2025 | 50d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 7, 2025 | Quarterly ↗ | Jun 30, 2025 | 38d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 19, 2025 | Annual ↗ | Dec 31, 2024 | 50d |
| Nov 7, 2024 | Quarterly ↗ | Sep 30, 2024 | 38d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 8, 2024 | Quarterly ↗ | Mar 31, 2024 | 38d |
| Feb 21, 2024 | Annual ↗ | Dec 31, 2023 | 52d |
| Nov 7, 2023 | Quarterly ↗ | Sep 30, 2023 | 38d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 8, 2026 | Results · Regulation FD ↗ |
| Aug 10, 2026 | Results · Regulation FD ↗ |
| Jul 9, 2026 | Results · Regulation FD ↗ |
| Jun 24, 2026 | Director or officer change · Shareholder vote · Regulation FD ↗ |
| May 6, 2026 | Results · Regulation FD ↗ |
| Apr 20, 2026 | Director or officer change ↗ |
| Apr 8, 2026 | Results · Regulation FD ↗ |
| Feb 18, 2026 | Results · Regulation FD ↗ |
| Jan 28, 2026 | Results · Regulation FD ↗ |
| Jan 12, 2026 | Results · Regulation FD ↗ |
| Nov 18, 2025 | Director or officer change · Regulation FD ↗ |
| Nov 6, 2025 | Results · Regulation FD ↗ |